Home » Topics » Conferences

Conferences
RSS

Wakunaga develops new oral fluoroquinolones

Oct. 2, 1997

BioChem Therapeutic discovers new anti-HCMV agents

Oct. 2, 1997

New polyene antifungal antibiotic developed at Ajinomoto

Oct. 2, 1997

Quinacrine sterilization reviewed

Oct. 2, 1997

Safety profile of VRCTC-310 established in rabbits

Oct. 2, 1997

ABT-606: a new orally active diester prodrug of H2G

Oct. 1, 1997

New agents for NIDDM presented by Pharmacia & Upjohn

Oct. 1, 1997

A-5021: a potent and selective antiherpesvirus agent from Ajinomoto

Oct. 1, 1997

Single- and multiple-dose clinical studies reported for SL-91.0102

Oct. 1, 1997

New treatment for ISH evaluated in humans

Oct. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...